Genomics
The recently completed analysis of the human genome provides enormous opportunities to delineate the molecular pathogenesis of common diseases and to develop specific diagnostic and therapeutic tools. Genomics using SNP genotyping and related technologies constitutes a key element in LIFE & BRAIN. The GENOMICS platform can build on ample expertise at the local neuroscience center in the identification of susceptibility genes associated with complex genetic diseases such as manic depression, schizophrenia or certain forms of epilepsy.
